Health care stocks fell Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 1%.
The iShares Biotechnology ETF (IBB) was down 0.9%.
In corporate news, Protara Therapeutics (TARA) shares surged 85% after the company said its investigational therapy TARA-002 showed a complete response rate of 72% at six months in a phase 2 trial involving people with non-muscle invasive bladder cancer.
Novo Nordisk (NVO) said Thursday it plans to significantly reduce the list price paid by US customers for its Tresiba and Fiasp insulin products starting January 2026. Its shares eased 0.2%.
Nano-X Imaging (NNOX) shares popped 2.4% after the company said it received 510(k) clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。